These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6108117)

  • 1. Quantitative structure-activity relationship in 1-substituted ureidophenoxy-3-amino-2-propanols, a class of beta-adrenergic blocking agents.
    Borea PA; Bonora A; Bertolasi V; Gilli G
    Arzneimittelforschung; 1980; 30(10):1613-7. PubMed ID: 6108117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-Adrenergic blocking agents. 15. 1-Substituted ureidophenoxy-3-amino-2-propanols.
    Smith LH
    J Med Chem; 1977 May; 20(5):705-8. PubMed ID: 16137
    [No Abstract]   [Full Text] [Related]  

  • 3. An experimental design based quantitative structure-activity relationship study on beta-adrenergic blocking agents using PLS.
    Norinder U
    Drug Des Discov; 1991 Dec; 8(2):127-36. PubMed ID: 1686560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative structure-activity relationships. Fujita-Ban analysis of beta-adrenergic blocking activity of 1-phenoxy-3-([(substituted amido)alkyl]amino)-2-propanols.
    Gombar V
    Arzneimittelforschung; 1986 Jul; 36(7):1014-8. PubMed ID: 2876713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-adrenergic blocking agents. 22. 1-Phenoxy-3-[[(substituted-amido) alkyl]amino]-2-propanols.
    Lare MS; Smith LH
    J Med Chem; 1982 Nov; 25(11):1286-92. PubMed ID: 6128420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nondepressant beta-adrenergic blocking agents. 1. Substituted 3-amino-1-(5,6,7,8-tetrahydro-1-naphthoxy)-2-propanols.
    Condon ME; Cimarusti CM; Fox R; Narayanan VL; Reid J; Sundeen JE; Hauck FP
    J Med Chem; 1978 Sep; 21(9):913-22. PubMed ID: 31485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and beta-adrenergic antagonist activity of novel (3-cyanodihydropyridyl)propanolamines.
    Vo D; Wolowyk MW; Knaus EE
    Drug Des Discov; 1991 Dec; 8(2):157-64. PubMed ID: 1686561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and beta-adrenergic antagonist activity of novel (3-oxazolinyl-1,4-dihydropyridyl) propanolamines.
    Vo D; Wolowyk MW; Knaus EE
    Drug Des Discov; 1992 Jul; 8(4):265-72. PubMed ID: 1359908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-Adrenergic blocking agents. 23. 1-[Substituted-amido)phenoxy]-3-[[(substituted-amido)alkyl]amino] propan-2-ols.
    Large MS; Smith LH
    J Med Chem; 1983 Mar; 26(3):352-7. PubMed ID: 6131134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dependence of the beta-adrenergic blocking action on the chemical structure in alylphenoxypropanolamine derivatives].
    Chekman IS; Simon IB
    Farm Zh; 1975; 30(4):61-4. PubMed ID: 2493
    [No Abstract]   [Full Text] [Related]  

  • 11. beta-Adrenergic blocking agents. 16. 1-(Acylaminomethyl-, ureidomethyl-, and ureidoethylphenoxy)-3-amino-2-propanols.
    Smith LH
    J Med Chem; 1977 Oct; 20(10):1254-8. PubMed ID: 20502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Beta-1 and beta-2 blocking activities of a new series of (arylalkoxy) propanolamines].
    Rosell G; Mauleón D; Pujol MD; Granados R
    Arch Farmacol Toxicol; 1986 Apr; 12(1):65-70. PubMed ID: 2874776
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and cardioselective beta-adrenergic antagonist activity of quinolyloxypropanolamines.
    Vo D; Wolowyk MW; Knaus EE
    Drug Des Discov; 1992; 9(1):69-78. PubMed ID: 1360842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A structure activity relationship study on 1-isopropylamino-3-(2'-substituted naphthoxy)-propan-2-ois analogs.
    Srivastava AK; Mishra N; Khan AA; Gupta DK
    Res Commun Mol Pathol Pharmacol; 1994 Sep; 85(3):351-4. PubMed ID: 7827810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and beta-adrenergic antagonist activity of heterocyclic propanolamines.
    Vo D; Wolowyk MW; Knaus EE
    Drug Des Discov; 1993 Jun; 10(2):89-99. PubMed ID: 8104518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and adrenergic beta-blocking activity of ortho-, meta- and para-oxypropanolamino-substituted [(benzylideneamino)oxy]propanolamines.
    Balsamo A; Lapucci A; Macchia B; Macchia M; Orlandini E; Rossello A; Ferni G; Pinza M
    Farmaco; 1995 Apr; 50(4):239-43. PubMed ID: 7669168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. beta-Adrenoceptor blocking activity of 3-alkylamino-1-(3-benzo[ b ]thienyloxy)-2-propanols and closely related bicyclic compounds.
    Conde S; Corral C; Lissavetzky J; Darias V; Galván O
    Arch Pharm (Weinheim); 1983 Jun; 316(6):537-44. PubMed ID: 6136264
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the synthesis of compounds with beta-adrenergic activity (author's transl)].
    Lehmann D; Eckardt R; Faust G; Fiedler W
    Pharmazie; 1980; 34(5-6):278-84. PubMed ID: 6106206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Structure-activity relationship of phenoxyalkanolamine derivatives with selective beta 1-receptor blocking action].
    Femmer K
    Pharmazie; 1975 Oct; 30(10):638-42. PubMed ID: 687
    [No Abstract]   [Full Text] [Related]  

  • 20. [Adrenergic beta receptor blockaders. IV. 1-(Hydroxy- or dihydroxyphenoxy)-3-isopropylamino-2-propanols].
    Casagrande C; Ferrini R; Miragoli G; Ferrari G
    Boll Chim Farm; 1973 Jul; 112(7):445-54. PubMed ID: 4148774
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.